Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.7K
Clinical Trials01:16

Clinical Trials

9.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.6K
Randomized Experiments01:13

Randomized Experiments

8.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.2K
Blinding01:11

Blinding

3.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.5K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

487
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
487
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

196
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
196

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Civic Engagement, Positive Organizational Sentiment, and Health in Baltimore, Maryland.

Journal of urban health : bulletin of the New York Academy of Medicine·2026
Same author

Evaluating the alignment of generic recipes with Canada's food guide 2019 using the Canadian Food Scoring System for recipes.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme·2026
Same author

Sodium in Canadian processed foods between 2010 and 2020: implications for future sodium reduction initiatives.

Public health nutrition·2026
Same author

Protecting Low-Wage Workers From Exploitation: A Mapping Study of Wage Theft Laws in the 40 Largest US Cities.

American journal of public health·2026
Same author

Policy gap: most child-appealing packaged food products in Canada will display a 'high in' front-of-package nutrition symbol.

Public health nutrition·2025
Same author

Assessing the extent to which front-of-pack labelling regulations could support healthy eating among Canadians.

PloS one·2025

Related Experiment Video

Updated: Oct 11, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.9K

COVID-19: A Catalyst for Transforming Randomized Trials.

Jennifer J Lee1, Jerri C Price1, William M Jackson1

  • 1Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY.

Journal of Neurosurgical Anesthesiology
|December 6, 2021
PubMed
Summary
This summary is machine-generated.

The COVID-19 pandemic accelerated clinical trials, yielding successes in adaptive designs and open science, but also failures in study execution and data integrity. Lessons learned can transform future clinical trial research.

More Related Videos

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

939
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.9K

Related Experiment Videos

Last Updated: Oct 11, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.9K
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

939
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.9K

Area of Science:

  • Clinical Trials
  • Epidemiology
  • Medical Research

Background:

  • The COVID-19 pandemic spurred rapid, high-volume global clinical trial research.
  • This unprecedented research activity presented both significant successes and failures.

Purpose of the Study:

  • To analyze the successes and failures of COVID-19 clinical trials.
  • To identify lessons learned for improving future clinical trial design and execution.
  • To compare COVID-19 trial experiences with those in anesthesiology and other medical fields.

Main Methods:

  • Review and analysis of clinical trial implementation during the COVID-19 pandemic.
  • Juxtaposition of COVID-19 trial experiences with historical data from other medical fields.
  • Identification of key challenges including study design, data integrity, and research waste.

Main Results:

  • Successes included large adaptive trials, rapid data synthesis, and open science principles.
  • Failures encompassed inadequate study design, data reversal/fraud, and research duplication.
  • Highlighted challenges involved unbiased designs for nonpharmaceutical interventions and using routinely collected data.

Conclusions:

  • The COVID-19 clinical trial experience offers critical lessons for the scientific community.
  • Addressing identified failures can enhance the efficiency, integrity, and impact of future research.
  • These lessons can serve as a catalyst for transforming clinical trial methodologies across disciplines.